Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Teva's innovative portfolio continues to drive strong performance and future potential. The company has announced its target ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Discover the top 7 undervalued Oil, Gas & Consumable Fuels stocks for Thursday, May 29 based on AAII’s Stock Grades.

VANCOUVER, BC / ACCESS Newswire / May 29, 2025 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF) ("Revolve" or the "Company"), a North American owner, operator and developer of renewable energy ...

IHG Hotels & Resorts has unveiled the launch of its 50th operational hotel in India with the opening of a Crowne Plaza ...

The Company's expansion efforts come amid an increase in the global focus on scalable respiratory solutions, which may position the Company as a strategic platform for public health initiatives and ...

At Artemis' ILS NYC 2025 conference, a high-profile panel of industry figures discussed how the maturing catastrophe bond ...

The two main areas for enhancing operations for enhanced productivity and growth are the increase in efficiency and control ...

Perma-Pipe International Holdings' FY 2024 12% revenue growth and steady margins balance with macro risks. Click here to read ...

Although a number of its managers have retired in recent years, American Funds American Balanced ABALX retains substantial ...

The New York City pension system’s recent sale of $5 billion in private equity assets on the secondary market represents ...